Haleon (FRA:H6D) Total Debt per Share: €2.16 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6D Haleon PLC FRA:H6D
73 GF Score
Price €8.30
GF Value €8.82
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Haleon Total Debt per Share?

Haleon FRA:H6D -1.78% 73 Total Debt per Share is €2.16 as of Jun. 2026. GuruFocus rates FRA:H6D with a GF Score™ of 73/100 and a GF Value™ of €8.82 (Fairly Valued). The stock has 2 warning signs investors should review.

€2.16 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Haleon's Total Debt Per Share for the quarter that ended in Jun. 2026 was €2.16.

Haleon Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Haleon's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haleon Total Debt per Share Chart

Haleon Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial 0.25 2.60 2.37 2.69 2.20

Haleon Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.30 2.69 2.21 2.20 2.16
FRA:H6D
73GF Score
Haleon PLC FRA:H6D
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haleon Total Debt per Share Calculation

Haleon's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(8,858+956)/4,453
=2.20

Haleon's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(7,251+2,271)/4,404
=2.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of €2.16 mean?
Haleon (FRA:H6D) has a Total Debt per Share of €2.16 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Haleon and its competitors.
Is Haleon's Total Debt per Share too high?
Haleon's current Total Debt per Share is €2.16. Overall, Haleon has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Haleon's Total Debt per Share compare to ZTS and UTHR?
Haleon's Total Debt per Share of €2.16 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Drug Manufacturers company?
A good Total Debt per Share depends on the Drug Manufacturers industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Haleon and its competitors. Haleon's current Total Debt per Share is €2.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haleon stock overvalued right now?
Based on GuruFocus' analysis, Haleon (FRA:H6D) is currently considered Fairly Valued. The stock's GF Value™ is €8.82, compared to a current price of €8.30 — trading 5.9% below its estimated fair value. The current Total Debt per Share is €2.16. Haleon's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Haleon (FRA:H6D), the current Total Debt per Share is €2.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haleon (FRA:H6D) Overvalued in 2026?

Based on GuruFocus' analysis, Haleon stock appears to be undervalued. The current stock price of €8.30 is trading 5.9% below its estimated GF Value™ of €8.82. GuruFocus considers Haleon to be Fairly Valued.

Key valuation signals for FRA:H6D:

  • Total Debt per Share: €2.16
  • GF Value™: €8.82 vs. price of €8.30 (5.9% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the FRA:H6D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haleon Business Description

Address The Heights, Building 5, First Floor, Weybridge, Surrey, GBR, KT13 0NY
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
73GF Score

Get the complete analysis for FRA:H6D

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.30
Price
€8.82
GF Value